Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
- PMID: 15056096
- DOI: 10.1111/j.1572-0241.2004.04067.x
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
Abstract
Cholangiocarcinoma (CCA) is a dreaded complication of primary sclerosing cholangitis (PSC); however, marked variability in the incidence of CCA in PSC is reported. Furthermore, limited information exists on risk factors for the development of CCA in PSC. The aim of this study was to determine the incidence of CCA in patients with PSC and to evaluate baseline risk factors for the later development of CCA. From a previous study of the natural history of PSC, we identified 161 patients with PSC who did not have CCA at study entry. Patients were followed until a diagnosis of CCA was established, liver transplantation was performed, or death occurred. Patients were followed for a median of 11.5 yr (interquartile range 4.0-16.1 yr). Fifty-nine patients (36.6%) died, 50 patients (31.1%) underwent liver transplantation, and 11 patients (6.8%) developed CCA. The rate of CCA developing was approximately 0.6% per year. Compared to the incidence rates of CCA in the general population, the relative risk of CCA in PSC was significantly increased (RR = 1,560; 95%CI = 780, 2,793; p < 0.0001). On univariate analysis, a history of variceal bleeding (p < 0.001), proctocolectomy (p= 0.01), and lack of symptoms (p= 0.02) were significant risk factors for CCA with the Mayo Risk Score being marginally significant (p= 0.051). Multivariate analysis determined only variceal bleeding to be a significant risk factor for CCA (RR 24.2; 95%CI: 3.3-67.1). No association was found between the duration of PSC and the incidence of CCA. In conclusion, approximately 7% of PSC patients later developed CCA over a mean follow-up of 11.5 yr, which is dramatically higher than the rates in the general population. Variceal bleeding is a major risk factor for the later development of CCA.
Similar articles
-
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.Hepatology. 2000 Jan;31(1):7-11. doi: 10.1002/hep.510310103. Hepatology. 2000. PMID: 10613720
-
Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.Am J Surg Pathol. 2010 Jan;34(1):27-34. doi: 10.1097/PAS.0b013e3181bc96f9. Am J Surg Pathol. 2010. PMID: 19898228
-
Primary sclerosing cholangitis and cholangiocarcinoma.Semin Liver Dis. 2006 Feb;26(1):42-51. doi: 10.1055/s-2006-933562. Semin Liver Dis. 2006. PMID: 16496232 Review.
-
Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.Rev Gastroenterol Disord. 2009 Spring;9(2):E41-7. Rev Gastroenterol Disord. 2009. PMID: 19668124 Review.
-
High lifetime risk of cancer in primary sclerosing cholangitis.J Hepatol. 2009 Jan;50(1):158-64. doi: 10.1016/j.jhep.2008.08.013. Epub 2008 Oct 14. J Hepatol. 2009. PMID: 19012991
Cited by
-
Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies.Sci Rep. 2021 May 20;11(1):10646. doi: 10.1038/s41598-021-90175-w. Sci Rep. 2021. PMID: 34017024 Free PMC article.
-
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.World J Gastrointest Oncol. 2021 Oct 15;13(10):1336-1366. doi: 10.4251/wjgo.v13.i10.1336. World J Gastrointest Oncol. 2021. PMID: 34721770 Free PMC article. Review.
-
Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.Curr Gastroenterol Rep. 2011 Apr;13(2):182-7. doi: 10.1007/s11894-011-0178-8. Curr Gastroenterol Rep. 2011. PMID: 21271364 Review.
-
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma.Carcinogenesis. 2009 Jul;30(7):1147-54. doi: 10.1093/carcin/bgp118. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443904 Free PMC article.
-
Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.Liver Transpl. 2011 Nov;17(11):1355-63. doi: 10.1002/lt.22396. Liver Transpl. 2011. PMID: 21837735 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical